Cart
sales@molnova.com
ecMetAP-IN-1
CAS No. 7471-12-7
ecMetAP-IN-1( —— )
Catalog No. M35307 CAS No. 7471-12-7
ecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | Get Quote |
|
| 10MG | 54 | Get Quote |
|
| 25MG | 82 | Get Quote |
|
| 50MG | 121 | Get Quote |
|
| 100MG | 172 | Get Quote |
|
| 200MG | 255 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameecMetAP-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
-
DescriptionecMetAP-IN-1 (compound 17) is a potent ecMetAP inhibitor with an IC50 value of 2.086 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7471-12-7
-
Formula Weight209.25
-
Molecular FormulaC13H11N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=C2N=C(NC2=CC1)C3=CC=CC=N3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schiffmann R, et al. Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions. J Med Chem. 2006 Jan 26;49(2):511-22.?
molnova catalog
related products
-
Fraxinol
Fraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one.
-
5-Furfurylidene-2-Th...
5-Furfurylidene-2-Thiobarbituric Acid is a tyrosyl-DNA phosphodiesterase inhibitor.
-
Amylin, amide, human
Amylin, a 37-amino acid polypeptide that is structurally related to calcitonin, is secreted from the B cells of the pancreas. Amylin has anoretic effects in rats. Amylin may be responsible for the etiology of insulin resistance of type II diabetes mellitus through its modulation of peripheral effects of insulin.
